Adachi, Y., Yanagimura, N., Suzuki, C., Ootani, S., Tanimoto, A., Nishiyama, A., . . . Yano, S. (2020). Reduced doses of dabrafenib and trametinib combination therapy for BRAF V600E-mutant non-small cell lung cancer prevent rhabdomyolysis and maintain tumor shrinkage: A case report. BMC Cancer.
Citación estilo ChicagoAdachi, Yuta, et al. "Reduced Doses of Dabrafenib and Trametinib Combination Therapy for BRAF V600E-mutant Non-small Cell Lung Cancer Prevent Rhabdomyolysis and Maintain Tumor Shrinkage: A Case Report." BMC Cancer 2020.
Cita MLAAdachi, Yuta, et al. "Reduced Doses of Dabrafenib and Trametinib Combination Therapy for BRAF V600E-mutant Non-small Cell Lung Cancer Prevent Rhabdomyolysis and Maintain Tumor Shrinkage: A Case Report." BMC Cancer 2020.